金城医药：2025年半年度净利润约4338万元

Core Viewpoint - Jincheng Pharmaceutical reported a significant decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its business operations and market conditions [2]. Financial Performance - The company's revenue for the first half of 2025 was approximately 1.36 billion yuan, representing a year-on-year decrease of 22.65% [2]. - The net profit attributable to shareholders was around 43.38 million yuan, down 66.78% compared to the previous year [2]. - Basic earnings per share were reported at 0.11 yuan, reflecting a decrease of 67.65% year-on-year [2].